Cargando…
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial
Docetaxel associated with oxaliplatin and 5-fluorouracil (FLOT) has been reported as the best perioperative treatment for gastric cancer. However, there is still some debate about the most appropriate number and timing of chemotherapy cycles. In this randomized multicenter phase II study, patients w...
Autores principales: | Monti, Manlio, Morgagni, Paolo, Nanni, Oriana, Framarini, Massimo, Saragoni, Luca, Marrelli, Daniele, Roviello, Franco, Petrioli, Roberto, Fumagalli Romario, Uberto, Rimassa, Lorenza, Bozzarelli, Silvia, Donini, Annibale, Graziosi, Luigina, De Angelis, Verena, De Manzoni, Giovanni, Bencivenga, Maria, Mengardo, Valentina, Parma, Emilio, Milandri, Carlo, Mura, Gianni, Signorini, Alessandra, Baiocchi, Gianluca, Molfino, Sarah, Sgroi, Giovanni, Steccanella, Francesca, Rausei, Stefano, Proserpio, Ilaria, Viganò, Jacopo, Brugnatelli, Silvia, Rinnovati, Andrea, Santi, Stefano, Ercolani, Giorgio, Foca, Flavia, Valmorri, Linda, Amadori, Dino, Frassineti, Giovanni Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599648/ https://www.ncbi.nlm.nih.gov/pubmed/33003302 http://dx.doi.org/10.3390/cancers12102790 |
Ejemplares similares
-
Conversion Surgery in Gastric Cancer Carcinomatosis
por: Morgagni, Paolo, et al.
Publicado: (2022) -
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series
por: Baiocchi, Gian Luca, et al.
Publicado: (2017) -
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry
por: Baiocchi, Gian Luca, et al.
Publicado: (2022) -
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer
por: Monti, Manlio, et al.
Publicado: (2023) -
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2019)